MedDataX Logo

Continence After Vaginal Prolapse Surgery

NCT ID: NCT05312047

Last Updated: 2025-12-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

609 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-04-04

Study Completion Date

2025-09-19

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Urinary incontinence after surgical correction of pelvic organ prolapse (POP) could occur. This is a condition that decreases both patients' satisfaction and quality of life. Reports on the prevalence of urinary incontinence after POP surgery are controversial. Concomitant surgery for incontinence could reduce this prevalence, whereas it increases treatment costs and the likelihood of surgical complications. Therefore, it is of paramount importance to know the exact prevalence of urinary incontinence after POP surgery in our population and the potential risk factors associated with this condition.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pelvic Organ Prolapse Urinary Incontinence

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Pelvic organ prolapse Surgery Urinary incontinence Stress urinary incontinence Urge-urinary incontinence

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Pelvic organ prolapse surgery

Vaginal surgery of any compartment for pelvic organ prolapse

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Women who will undergo vaginal surgery for pelvic organ prolapse.

Exclusion Criteria

* Inability to give consent to the study.
Minimum Eligible Age

18 Years

Maximum Eligible Age

99 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Consorci Sanitari de Terrassa

OTHER

Sponsor Role collaborator

Parc Taulí Hospital Universitari

OTHER

Sponsor Role collaborator

Hospital de Viladecans

OTHER

Sponsor Role collaborator

Hospital Universitari de Bellvitge

OTHER

Sponsor Role collaborator

Hospital d'Igualada

OTHER

Sponsor Role collaborator

Hospital de Mataró

OTHER

Sponsor Role collaborator

Fundació Hospital de l'Esperit Sant

UNKNOWN

Sponsor Role collaborator

Germans Trias i Pujol Hospital

OTHER

Sponsor Role collaborator

Hospital Santa Caterina

UNKNOWN

Sponsor Role collaborator

Hospital de Granollers

OTHER

Sponsor Role collaborator

Hospital del Mar

OTHER

Sponsor Role collaborator

Hospital Universitari Joan XXIII de Tarragona.

OTHER

Sponsor Role collaborator

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

OTHER

Sponsor Role collaborator

Hospital Universitari Vall d'Hebron Research Institute

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Marina Catalan, MD

Role: PRINCIPAL_INVESTIGATOR

Vall d'Hebron Barcelona Hospital Campus

Jordi Sabadell, MD

Role: STUDY_DIRECTOR

Vall d'Hebron Barcelona Hospital Campus

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital Germans Trias i Pujol

Badalona, Barcelona, Spain

Site Status

Vall d'Hebron Barcelona Hospital Campus

Barcelona, Barcelona, Spain

Site Status

Hospital General de Granollers

Granollers, Barcelona, Spain

Site Status

Hospital d'Igualada

Igualada, Barcelona, Spain

Site Status

Hospital General de l'Hospitalet

L'Hospitalet de Llobregat, Barcelona, Spain

Site Status

Hospital Universitari de Bellvitge

L'Hospitalet de Llobregat, Barcelona, Spain

Site Status

Parc Taulí Hospital Universitari

Sabadell, Barcelona, Spain

Site Status

Hospital de l'Esperit Sant

Santa Coloma de Gramenet, Barcelona, Spain

Site Status

Consorci Sanitari de Terrassa

Terrassa, Barcelona, Spain

Site Status

Hospital de Viladecans

Viladecans, Barcelona, Spain

Site Status

Hospital de Sant Pau

Barcelona, , Spain

Site Status

Hospital del Mar

Barcelona, , Spain

Site Status

Hospital Santa Caterina

Girona, , Spain

Site Status

Hospital Joan XXIII

Tarragona, , Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Spain

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PR(AMI)631-2021

Identifier Type: -

Identifier Source: org_study_id